PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 21 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,350,309 | -5.2% | 7,907,000 | +2.6% | 0.86% | -6.8% |
| Q4 2022 | $6,695,649 | -2.0% | 7,707,000 | 0.0% | 0.92% | -4.5% |
| Q3 2022 | $6,831,485 | +3.9% | 7,707,000 | 0.0% | 0.97% | -4.4% |
| Q2 2022 | $6,575,000 | -4.9% | 7,707,000 | 0.0% | 1.01% | +8.1% |
| Q1 2022 | $6,912,000 | -8.5% | 7,707,000 | -6.1% | 0.94% | +3.9% |
| Q4 2021 | $7,550,000 | -7.5% | 8,207,000 | -11.3% | 0.90% | -24.7% |
| Q3 2021 | $8,164,000 | +34.1% | 9,257,000 | +38.0% | 1.20% | +63.0% |
| Q2 2021 | $6,087,000 | – | 6,707,000 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cohanzick Management, LLC | 25,112,000 | $25,557,982 | 22.10% |
| Westchester Capital Management, LLC | 8,267,000 | $8,308,536 | 0.24% |
| MACQUARIE GROUP LTD | 5,359,000 | $5,386,000 | 0.01% |